ES2986444T3 - Uso intradialítico de nitrito sódico - Google Patents

Uso intradialítico de nitrito sódico Download PDF

Info

Publication number
ES2986444T3
ES2986444T3 ES18763384T ES18763384T ES2986444T3 ES 2986444 T3 ES2986444 T3 ES 2986444T3 ES 18763384 T ES18763384 T ES 18763384T ES 18763384 T ES18763384 T ES 18763384T ES 2986444 T3 ES2986444 T3 ES 2986444T3
Authority
ES
Spain
Prior art keywords
nitrite
dialysate
sodium nitrite
subject
enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18763384T
Other languages
English (en)
Spanish (es)
Inventor
Craig Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hope Medical Enterprises Inc
Original Assignee
Hope Medical Enterprises Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hope Medical Enterprises Inc filed Critical Hope Medical Enterprises Inc
Application granted granted Critical
Publication of ES2986444T3 publication Critical patent/ES2986444T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES18763384T 2017-03-08 2018-03-06 Uso intradialítico de nitrito sódico Active ES2986444T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762468857P 2017-03-08 2017-03-08
PCT/US2018/021053 WO2018165098A1 (en) 2017-03-08 2018-03-06 Intradialytic use of sodium nitrite

Publications (1)

Publication Number Publication Date
ES2986444T3 true ES2986444T3 (es) 2024-11-11

Family

ID=63445965

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18763384T Active ES2986444T3 (es) 2017-03-08 2018-03-06 Uso intradialítico de nitrito sódico

Country Status (15)

Country Link
US (5) US10328099B2 (https=)
EP (2) EP4406595A3 (https=)
JP (3) JP7314050B2 (https=)
KR (4) KR20250017763A (https=)
AR (1) AR111166A1 (https=)
AU (2) AU2018231016B2 (https=)
BR (1) BR112019018861A2 (https=)
CA (1) CA3055105A1 (https=)
ES (1) ES2986444T3 (https=)
IL (4) IL312092B2 (https=)
NZ (4) NZ797744A (https=)
PH (1) PH12019501950A1 (https=)
TW (3) TWI835595B (https=)
WO (1) WO2018165098A1 (https=)
ZA (3) ZA201905679B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019018861A2 (pt) * 2017-03-08 2023-10-10 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa
IL268883B (en) 2017-03-08 2022-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
EP4005611B1 (en) * 2019-07-22 2025-11-26 School Juridical Person The Kitasato Institute Dialysis device
US20230149732A1 (en) * 2021-11-17 2023-05-18 Wake Forest University Health Sciences Combined nitrite and light treatment to prevent device thrombosis
CN120456938A (zh) 2022-12-16 2025-08-08 费森尤斯医疗保健控股公司 用于在透析中使用一氧化氮的系统和方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218900B1 (en) 1985-09-10 1992-01-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
JP5564158B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7547637B2 (en) * 2005-06-21 2009-06-16 Intel Corporation Methods for patterning a semiconductor film
US20090304600A1 (en) 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
AU2010270605B2 (en) 2009-07-08 2014-07-31 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions
CA2844759A1 (en) * 2011-08-11 2013-02-14 Nathan S. Bryan Method of measuring and monitoring in vivo nitrite levels
WO2013112582A1 (en) 2012-01-23 2013-08-01 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
JP5486069B1 (ja) 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
JP6183832B2 (ja) * 2013-06-19 2017-08-23 扶桑薬品工業株式会社 酸化ストレス抑制型透析用剤およびその調製方法
BR112019018861A2 (pt) * 2017-03-08 2023-10-10 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa

Also Published As

Publication number Publication date
TW202421096A (zh) 2024-06-01
US12011456B2 (en) 2024-06-18
AR111166A1 (es) 2019-06-12
AU2024203535A1 (en) 2024-06-20
TWI888012B (zh) 2025-06-21
KR20250017763A (ko) 2025-02-04
IL312092A (en) 2024-06-01
TW201836594A (zh) 2018-10-16
WO2018165098A1 (en) 2018-09-13
US20180256637A1 (en) 2018-09-13
IL284684B2 (en) 2023-08-01
AU2018231016B2 (en) 2024-03-07
IL268882A (en) 2019-10-31
JP2024174935A (ja) 2024-12-17
ZA202208504B (en) 2024-01-31
KR102706379B1 (ko) 2024-09-19
EP3592342B1 (en) 2024-06-19
IL284684A (en) 2021-08-31
IL268882B (en) 2021-07-29
IL312092B1 (en) 2025-04-01
IL301302A (en) 2023-05-01
US20240285677A1 (en) 2024-08-29
US20190255098A1 (en) 2019-08-22
ZA201905679B (en) 2023-02-22
CA3055105A1 (en) 2018-09-13
US11564938B2 (en) 2023-01-31
US20210077524A1 (en) 2021-03-18
EP4406595A2 (en) 2024-07-31
IL301302B2 (en) 2024-09-01
KR102760913B1 (ko) 2025-02-03
ZA202307367B (en) 2024-11-27
BR112019018861A2 (pt) 2023-10-10
US20230256005A1 (en) 2023-08-17
IL301302B1 (en) 2024-05-01
IL284684B1 (en) 2023-04-01
PH12019501950A1 (en) 2020-06-15
JP2023134621A (ja) 2023-09-27
US10328099B2 (en) 2019-06-25
TW202325265A (zh) 2023-07-01
US10898512B2 (en) 2021-01-26
JP2020510014A (ja) 2020-04-02
JP7551858B2 (ja) 2024-09-17
KR20190130588A (ko) 2019-11-22
NZ756701A (en) 2022-07-01
TWI798203B (zh) 2023-04-11
KR20240038812A (ko) 2024-03-25
KR102647803B1 (ko) 2024-03-15
AU2024203535B2 (en) 2026-04-23
NZ797740A (en) 2026-02-27
EP4406595A3 (en) 2024-10-30
NZ789172A (en) 2026-02-27
KR20240137711A (ko) 2024-09-20
EP3592342A1 (en) 2020-01-15
JP7314050B2 (ja) 2023-07-25
NZ797744A (en) 2026-02-27
AU2018231016A1 (en) 2019-09-19
TWI835595B (zh) 2024-03-11
EP3592342A4 (en) 2020-12-23
IL312092B2 (en) 2025-08-01
JP7765687B2 (ja) 2025-11-07

Similar Documents

Publication Publication Date Title
US12011456B2 (en) Intradialytic use of sodium nitrite
US12370212B2 (en) Intradialytic use of sodium thiosulfate
TWI915123B (zh) 包含硫代硫酸鈉之醫藥組合物
BR112019018646B1 (pt) Uso de tiossulfato de sódio, solução aquosa